Utah Medical Prod (UTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,409 | 3,956 | 16,635 | 12,349 | 8,414 |
| Depreciation Amortization | 1,376 | 683 | 6,368 | 5,328 | 3,543 |
| Income taxes - deferred | -364 | -192 | -693 | -284 | -137 |
| Accounts receivable | -297 | -214 | 2,270 | 2,133 | 2,044 |
| Accounts payable and accrued liabilities | 66 | 230 | -456 | -712 | 114 |
| Other Working Capital | -528 | 749 | -233 | -578 | -75 |
| Other Operating Activity | 376 | 64 | -1,610 | -1,287 | -2,075 |
| Operating Cash Flow | $8,038 | $5,276 | $22,281 | $16,949 | $11,828 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -105 | 5 | -639 | -549 | -363 |
| Purchase Sale Intangibles | -5 | N/A | N/A | 0 | N/A |
| Other Investing Activity | -5 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-110 | $5 | $-639 | $-549 | $-363 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 390 | 96 | 117 | 117 | 81 |
| Common Stock Repurchased | -9,393 | -2,990 | N/A | 0 | N/A |
| Dividend Paid | -2,170 | -1,089 | -4,282 | -3,211 | -2,140 |
| Financing Cash Flow | $-11,173 | $-3,983 | $-4,165 | $-3,094 | $-2,059 |
| Exchange Rate Effect | -404 | -358 | 339 | -149 | 161 |
| Beginning Cash Position | 92,868 | 92,868 | 75,052 | 75,052 | 75,052 |
| End Cash Position | 89,219 | 93,808 | 92,868 | 88,209 | 84,619 |
| Net Cash Flow | $-3,649 | $940 | $17,816 | $13,157 | $9,567 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,038 | 5,276 | 22,281 | 16,949 | 11,828 |
| Capital Expenditure | -132 | -22 | -639 | -549 | -363 |
| Free Cash Flow | 7,906 | 5,254 | 21,642 | 16,400 | 11,465 |